Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older, or meet the minimum age required by local regulations.
- People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition).
- People whose doctor is planning to perform a procedure using a specific commercially available medical device called the PulseSelect™ PFA System.
- People who are willing to follow the study requirements and formally agree in writing to take part in the trial.
Who may not be able to join:
- People who are already enrolled in another clinical study that has not been approved to run alongside this one by the global study manager.
- People who fall under any exclusion criteria required by the laws or regulations in their local area (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Khaldoun Tarakji, MD, Medtronic CAS Chief Medical Officer
Phone: 7635050262
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy-Freedom from Atrial Fibrillation; Safety- Freedom from Device/Procedure Related Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.